BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/17/2021 6:19:34 AM | Browse: 603 | Download: 1352
 |
Received |
|
2020-11-08 08:56 |
|
Peer-Review Started |
|
2020-11-01 11:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-30 02:01 |
|
Revised |
|
2021-01-11 03:41 |
|
Second Decision |
|
2021-03-02 08:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-08 03:11 |
|
Articles in Press |
|
2021-03-08 03:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-16 06:34 |
|
Publish the Manuscript Online |
|
2021-03-17 06:19 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Waled Mohsen, Astrid-Jane Williams, Gabrielle Wark, Alexandra Sechi, Jenn-Hian Koo, Wei Xuan, Milan Bassan, Watson Ng and Susan Connor |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Waled Mohsen, FACP, Doctor, Doctor, Liverpool Hospital , AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital Missenden, Road Camperdown, Bigge Street Liverpool, Sydney 2170, Queensland, Australia. wmoh6298@uni.sydney.edu.au |
| Key Words |
Prep Kit-C; Moviprep; Efficacy; Tolerability; Inflammatory Bowel Disease; Bowel preparation |
| Core Tip |
When comparing Moviprep (Mp) and Prep-Kit C in patients with and without inflammatory bowel disease (IBD): (1) Efficacy, tolerability and safety of Mp and Prep-Kit C are similar; (2) Participants with IBD reported lower tolerability with both preparations; (3) IBD participants described more abdominal pain with Mp. Consideration of these results are important when discussing bowel preparation with IBD patients. |
| Publish Date |
2021-03-17 06:19 |
| Citation |
Mohsen W, Williams AJ, Wark G, Sechi A, Koo JH, Xuan W, Bassan M, Ng W, Connor S. Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy? World J Gastroenterol 2021; 27(11): 1090-1100 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i11/1090.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i11.1090 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
